LYCOS RETRIEVER 
Isis: Company Limited
built 268 days ago
At 9:00 a.m. Eastern Standard Time Tuesday, November 13, Isis will conduct a live webcast presentation of its Analyst & Investor Day. Interested parties may access the webcast at http://www.isispharm.com. A replay of the webcast will be available on Isis' web site for a limited time.
Source:
Isis will conduct a live webcast conference call to discuss this press release on Wednesday, May 31 at 8:30 am Eastern time. To participate over the Internet go to http://www.videonewswire.com/event.asp?id=34158 or http://www.isispharm.com. A replay of the webcast will be available at these addresses for a limited time.
Source:
Isis owns or controls more than 1,500 issued patents pertaining to nucleic acid based therapeutics. These patents have been exclusively licensed to Alnylam for double-stranded RNAi therapeutics and include, but are not limited to:
Source:
MORE ABOUT
Company Limited